Among the ways TGF-β is activated, it has been revealed that the integrin alpha-v beta-6 (ανβ6), which is expressed in CRC cells, is responsible for the activation of the latent form of TGF-β. The gene discussed is TGFB1; the disease is colorectal carcinoma.